Access sought to tuberculosis drug from nutraceutical company.
作者信息
Gruber Karl
出版信息
Nat Med. 2015 Feb;21(2):103. doi: 10.1038/nm.3805. Epub 2015 Feb 2.
DOI:10.1038/nm.3805
PMID:25642939
Abstract
摘要
相似文献
1
Access sought to tuberculosis drug from nutraceutical company.
Nat Med. 2015 Feb;21(2):103. doi: 10.1038/nm.3805. Epub 2015 Feb 2.
2
Timing is everything for compassionate use of delamanid.
Nat Med. 2015 Mar;21(3):211. doi: 10.1038/nm.3823.
3
Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis - United States, 2017.
MMWR Morb Mortal Wkly Rep. 2018 Sep 7;67(35):996-997. doi: 10.15585/mmwr.mm6735a6.
4
Delamanid for Extensively Drug-Resistant Tuberculosis.
N Engl J Med. 2015 Jul 16;373(3):291-2. doi: 10.1056/NEJMc1415332.
5
Compassionate and optimum use of new tuberculosis drugs.
Lancet Infect Dis. 2015 Oct;15(10):1131-1132. doi: 10.1016/S1473-3099(15)00296-0. Epub 2015 Sep 20.
6
Compassionate and optimum use of new tuberculosis drugs.
Lancet Infect Dis. 2015 Oct;15(10):1131. doi: 10.1016/S1473-3099(15)00294-7. Epub 2015 Sep 20.
7
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.
Eur Respir J. 2016 Sep;48(3):935-8. doi: 10.1183/13993003.00637-2016. Epub 2016 Jun 10.
8
Bedaquiline plus delamanid for XDR tuberculosis.
Lancet Infect Dis. 2016 Mar;16(3):294. doi: 10.1016/S1473-3099(16)00047-5.
9
Barriers to new drug development in respiratory disease.
Eur Respir J. 2016 Jan;47(1):356-7. doi: 10.1183/13993003.00783-2015.
10
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.
Eur Respir J. 2014 Sep;44(3):811-5. doi: 10.1183/09031936.00060414. Epub 2014 May 15.
引用本文的文献
1
Drug-Resistant Tuberculosis: Challenges and Progress.
Infect Dis Clin North Am. 2016 Jun;30(2):509-522. doi: 10.1016/j.idc.2016.02.010.
2
Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings.
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):163-72. doi: 10.1093/trstmh/trv107.
3
The role of delamanid in the treatment of drug-resistant tuberculosis.
Ther Clin Risk Manag. 2015 May 13;11:779-91. doi: 10.2147/TCRM.S71076. eCollection 2015.
4
Timing is everything for compassionate use of delamanid.
Nat Med. 2015 Mar;21(3):211. doi: 10.1038/nm.3823.
Zotero 插件